US Packaging Giant invests in ROLAND perfection

With annual sales of over $1 billion, Clondalkin Group operates in a wide range of packaging product sectors across international markets with over 40 production facilities in Europe and North America.

Clondalkin Pharma and Healthcare North America have added a Manroland Sheetfed 708 coater perfecting press with InlineFoiler to its PS9000 compliant pharmaceutical packaging production facility in Charlotte, North Carolina.

The press adds additional capacity, high quality color, UV ink and coating drying options along with inline foil application capability to the already well equipped facility which specializes in the production of folded cartons for the pharmaceutical sector.

Kevin Kenjarski, VP of Sales & Marketing at Clondalkin Pharma and Healthcare North America said; "As a forward thinking and customer focused business, investment in equipment that provides our customers access to the best quality products is of paramount importance to us. In the past six years we have invested $300 million in our Pharma and Healthcare packaging business, to drive our customer service capabilities. We offer our customers the most comprehensive network of accredited plants with 17 production sites in North America and Europe. All of these plants are well invested and are leading standard setters for the industry offering distinctive innovation and service capabilities. Working together, the extensive production network promotes specialization and development of excellence centers to ensure best practice delivery every time." Kevin adds, "The award winning Manroland InlineFoiler will allow for further value added enhancements on the sheet in-line with the ability to print over the foil that is applied in the second and third printing units."

The Charlotte facility produces best in class folded cartons to a customer base requiring pharmaceutical and healthcare secondary packaging with the latest brand security, sustainability and structural design solutions.

We are very pleased to have another uniquely configured Manroland Sheetfed press enter the Clondalkin Pharma and Healthcare North America package printing system. We very much look forward to continuing our relationship with this globally recognized packaging solutions provider.” says Michael Mugavero Managing Director of Manroland Inc.

About Clondalkin Pharma and Healthcare North America

With annual sales of over $1 billion, Clondalkin Group operates in a wide range of packaging product sectors across international markets with over 40 production facilities in Europe and North America. The Pharmaceutical and Healthcare division is a global supplier of printed components dedicated to producing cartons, labels and literature that fully comply with cGMP guidelines. An international footprint of 17 facilities, with 9 in North America, means Clondalkin Pharma & Healthcare is uniquely equipped to supply packaging solutions internationally to the highest quality standards with all the added benefits of local responsiveness and service. For more information about Clondalkin Pharma and Healthcare North America, visit www.clondalkingroup.com.

About Manroland Sheetfed

Manroland Sheetfed GmbH began trading on 10 February 2012, following the acquisition of the Sheetfed division of the insolvent manroland AG by British industrialist Tony Langley and Langley Holdings PLC (www.langleyholdings.com).

Manroland Sheetfed employs approx.1000 people at the HQ in Offenbach, Germany and around 2000 staff worldwide, in over 40 subsidiaries. For more information about Manroland Sheetfed, visit www.manroland.com.